The first person in Wales has received a ground-breaking haemophilia treatment at a brand new facility at the University ...

When you get IV vitamin infusions outside of a medical setting, it’s difficult to know what’s going into your body and how it ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

I don’t know about you, but I’ve always preferred making my own antibodies. Why outsource it? It’s so handy letting my own body do the work of fighting infections while I’m writing articles or ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that its Phase Ib/II study of ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera's Infusion Specialty Therapies Business Unit (IST). This strategic acq ...

BIRMINGHAM, Ala. ( WBRC) - Alabama Attorney General Steve Marshall has announced that the state settled a lawsuit with a ...

There are many different ways to fight aging -- by changing your diet, staying out of the sun or getting good sleep. A new ...

Biogen and Eisai recently announced that Chinese regulators have accepted their Biologics License Application for a subcutaneous, at‑home injectable version of Alzheimer’s drug LEQEMBI, advancing it ...

Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...